Story
19 October 2026
WHO Yemen: Yemen advances development of its Gavi 6.0 Holistic Application through a multistakeholder Consultative workshop
19 October 2026, Amman, Jordan – The World Health Organization (WHO), in collaboration with Gavi, the Vaccine Alliance, convened a three-day multistakeholder workshop in Amman to support the development of Yemen’s Holistic Application under the Gavi 6.0 strategic investment framework. The Gavi 6.0 investment period runs from July 2027 to December 2030, and the Application aims to establish a unified national vision for immunization, aligning vaccination priorities with primary health care and broader health system strengthening efforts.
Held from 4 to 6 October, the multistakeholder workshop brought together representatives from the Ministry of Public Health and Population (MOPHP), the Expanded Programme on Immunization,VPD Surveillance program , primary health care and health Education teams, regional and country Immunization technical expert of WHO, Gavi Secretariat , the UNICEF, civil society organizations and other key partners.Over the Three days, participants reviewed Yemen’s immunization, surveillance and health system performance, including achievements, persistent challenges and lessons from previous Gavi 5.0 strategic periodsupported investments. Discussions also examined epidemiological and immunization coverage data, equity and zero-dose gaps, disease surveillance, laboratory capacity, vaccine supply and cold chain systems, health workforce needs, community engagement, data systems and financial sustainability and accountability. Particular attention was paid to identifying priority interventions to reach zero-dose and under-immunized children and communities, strengthen vaccine-preventable disease surveillance, improve vaccine delivery systems. Vaccine optimization and new vaccine introduction and ensure that future investments respond to Yemen’s operational realities.“Every child in Yemen, regardless of where they live or the challenges their community faces, should have equitable access to lifesaving vaccines. Through this collaborative process, we are working with national authorities and partners to translate evidence and lessons learned into practical investments that can reach zero-dose and under-immunized children while strengthening the systems that sustain immunization services,” said WHO Representative in Yemen Dr Syed Jaffar Hussain. The workshop provided a platform to consider gender, equity, fragility and conflict-sensitive approaches. Participants worked collectively to define implementation approaches, geographic priorities of interventions and new vaccine introduction , results frameworks, milestones and targets while examining financing requirements, sustainability considerations, implementation risks and the respective roles of national authorities and partners.Discussions focused on southern governorates of Yemen from 4 to 6 October 2026. The process is expected to result in an agreed and technically reviewed draft of Yemen’s Gavi 6.0 Holistic Application, including prioritized interventions aligned with investment areas, implementation and sequencing strategies, a timeline for new vaccine introduction, a results framework, financing assumptions, risk mitigation measures, and a clear roadmap for finalization and submission of the application.Through continued collaboration with the Ministry of Public Health and Population (MOPHP), Gavi, UNICEF, and other partners, WHO remains committed to providing technical leadership and supporting Yemen in strengthening immunization services, reaching children who have missed essential vaccines, introducing new vaccines, and building resilient systems for vaccine delivery, disease surveillance, and the integration of immunization within primary health care. Through the effective utilization of Gavi 6.0 investments, WHO will continue to support efforts aimed at safeguarding the health and future of Yemen’s children and ensuring equitable access to life-saving vaccines.
Held from 4 to 6 October, the multistakeholder workshop brought together representatives from the Ministry of Public Health and Population (MOPHP), the Expanded Programme on Immunization,VPD Surveillance program , primary health care and health Education teams, regional and country Immunization technical expert of WHO, Gavi Secretariat , the UNICEF, civil society organizations and other key partners.Over the Three days, participants reviewed Yemen’s immunization, surveillance and health system performance, including achievements, persistent challenges and lessons from previous Gavi 5.0 strategic periodsupported investments. Discussions also examined epidemiological and immunization coverage data, equity and zero-dose gaps, disease surveillance, laboratory capacity, vaccine supply and cold chain systems, health workforce needs, community engagement, data systems and financial sustainability and accountability. Particular attention was paid to identifying priority interventions to reach zero-dose and under-immunized children and communities, strengthen vaccine-preventable disease surveillance, improve vaccine delivery systems. Vaccine optimization and new vaccine introduction and ensure that future investments respond to Yemen’s operational realities.“Every child in Yemen, regardless of where they live or the challenges their community faces, should have equitable access to lifesaving vaccines. Through this collaborative process, we are working with national authorities and partners to translate evidence and lessons learned into practical investments that can reach zero-dose and under-immunized children while strengthening the systems that sustain immunization services,” said WHO Representative in Yemen Dr Syed Jaffar Hussain. The workshop provided a platform to consider gender, equity, fragility and conflict-sensitive approaches. Participants worked collectively to define implementation approaches, geographic priorities of interventions and new vaccine introduction , results frameworks, milestones and targets while examining financing requirements, sustainability considerations, implementation risks and the respective roles of national authorities and partners.Discussions focused on southern governorates of Yemen from 4 to 6 October 2026. The process is expected to result in an agreed and technically reviewed draft of Yemen’s Gavi 6.0 Holistic Application, including prioritized interventions aligned with investment areas, implementation and sequencing strategies, a timeline for new vaccine introduction, a results framework, financing assumptions, risk mitigation measures, and a clear roadmap for finalization and submission of the application.Through continued collaboration with the Ministry of Public Health and Population (MOPHP), Gavi, UNICEF, and other partners, WHO remains committed to providing technical leadership and supporting Yemen in strengthening immunization services, reaching children who have missed essential vaccines, introducing new vaccines, and building resilient systems for vaccine delivery, disease surveillance, and the integration of immunization within primary health care. Through the effective utilization of Gavi 6.0 investments, WHO will continue to support efforts aimed at safeguarding the health and future of Yemen’s children and ensuring equitable access to life-saving vaccines.
